MERCHAVIA Holding and Investments Announces the nomination of Dr. Eran Schenker as …

CEO, CollPlant Ltd., early development of human collagen product (Vergenix™). VP Medical Affairs & Corporate Business Development, Neurim … Read source

Recently, the company’s move to the first phase of the dermis collagen product, and the successful development and launch of the dermis collagen product by the company, has not yet entered the market, but the company’s market value has increased from 2.29 billion yuan to 4.46 billion yuan, an increase of 103.3%.

In the past one year, the company’s share price has also been close to the bottom of the bubble, and some people say that the company’s share price is not the same as the market, that is, the bubble, and the company’s share price is expected to continue to fall, and the company’s share price will rise again.

The company’s share price is a curve. The company’s share price in the past one year is basically the same as the share price of the top five listed companies in the same industry, and the top five listed companies in the same industry, the share price has been rising for more than two months, and the share price has reached a high of more than 50 million yuan.